ACTRN12618000659202招募中未知
Myeloma and Related Diseases Registry
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with a new diagnosis of multiple myeloma, plasmacytoma, plasma cell leukaemia or monoclonal gammopathy of undetermined significance (MGUS). Diagnosis within 3 months prior to HREC approval at a site for myeloma, plasmacytoma, plasma cell leukaemia and within 5 years for MGUS in order to minimise retrospective data collection.
排除标准
- •People who decline to participate in the registry.
研究者
相似试验
招募中
不适用
Clinical Myeloma Registry GMMGC.90.0DRKS00026970niversitätsklinikum Heidelberg999
已完成
不适用
Study to to evaluate the occurrence of Myeloproliferative neoplasm (a type of disease in which the bone marrow makes too many RBC, platelets, or certain WBC) & to characterize treatment patterns & burden/ symptoms of illness under routine medical practiceCTRI/2014/05/004598ovartis Healthcare Pvt Ltd
暂停
不适用
Myeloproliferative Neoplasms Registry (ALLG MPN01)Polycythaemia vera (PV)Essential thrombocythaemia (ET)Primary myelofibrosis (PMF)Myeloproliferative neoplasm – unclassifiable (MPN-NOS)Chronic eosinophilic leukaemia (CEL)Hypereosinophilic syndrome (HES)Refractory anaemia with ring sideroblasts associated with marked thrombocytosis (RARS-t)Cancer - Other cancer typesACTRN12613000138785Australasian Leukaemia and Lymphoma Group (ALLG)300
招募中
不适用
Working party multiple myeloma - OSHO registry of myelomaC90.0C90.3Solitary plasmacytomaMultiple myelomaDRKS00021041niversitätsklinikum Rostock2,500
未知
不适用
Registration Program for Myelodysplastic Syndromes and Aplastic AnemiaJPRN-UMIN000000694Keio University School of Medicine50